KISUNLA 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Eli Lilly Nederland B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: f2a349b76774cf48
Drug Cima Aemps Name: KISUNLA 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1251926001
Holder Company Name: Eli Lilly Nederland B.V.
Marketing Company Name: Lilly S.A.
Holder Company Detail Path: /organization/eli-lilly-nederland-bv
Marketing Company Detail Path: /organization/lilly-sa
Authorization Date: 2025-10-20
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 350 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Eli Lilly Nederland B.V.
Company Detail Path: /organization/eli-lilly-nederland-bv

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 20, 2025

Approval ID

f2a349b76774cf48

Type

Standard